Compile Data Set for Download or QSAR
Report error Found 89 Enz. Inhib. hit(s) with all data for entry = 12184
TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684732(US20240228491, Example 8 | 3-(1H-imidazol-2-yl)-4-...)
Affinity DataIC50: 8.70nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684743(US20240228491, Example 20)
Affinity DataIC50: 11.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684742(US20240228491, Example 19)
Affinity DataIC50: 12.3nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684705(US20240228491, Example 3)
Affinity DataIC50: 12.7nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684748(US20240228491, Example 25)
Affinity DataIC50: 13.3nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684753(US20240228491, Example 30)
Affinity DataIC50: 13.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684766(US20240228491, Example 44)
Affinity DataIC50: 13.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684758(US20240228491, Example 36)
Affinity DataIC50: 13.6nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684769(US20240228491, Example 47)
Affinity DataIC50: 13.6nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684800(US20240228491, Example 75)
Affinity DataIC50: 13.8nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684802(US20240228491, Example 77)
Affinity DataIC50: 13.9nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684803(US20240228491, Example 78)
Affinity DataIC50: 14nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684776(US20240228491, Example 53)
Affinity DataIC50: 14.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684779(US20240228491, Example 56)
Affinity DataIC50: 14.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684767(US20240228491, Example 45)
Affinity DataIC50: 14.8nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684757(US20240228491, Example 35)
Affinity DataIC50: 14.9nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684755(US20240228491, Example 32)
Affinity DataIC50: 14.9nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684745(US20240228491, Example 22)
Affinity DataIC50: 15nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684764(US20240228491, Example 42)
Affinity DataIC50: 15nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684768(US20240228491, Example 46)
Affinity DataIC50: 15.1nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684810(US20240228491, Example 85)
Affinity DataIC50: 15.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684789(US20240228491, Example 65)
Affinity DataIC50: 15.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684754(US20240228491, Example 31)
Affinity DataIC50: 15.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684788(US20240228491, Example 64)
Affinity DataIC50: 15.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684812(US20240228491, Example 87)
Affinity DataIC50: 15.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684805(US20240228491, Example 80)
Affinity DataIC50: 15.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684747(US20240228491, Example 24)
Affinity DataIC50: 15.6nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684772(US20240228491, Example 49 | US20240228491, Example...)
Affinity DataIC50: 15.8nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684811(US20240228491, Example 86)
Affinity DataIC50: 15.9nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684792(US20240228491, Example 68)
Affinity DataIC50: 16nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684772(US20240228491, Example 49 | US20240228491, Example...)
Affinity DataIC50: 16nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684807(US20240228491, Example 82)
Affinity DataIC50: 16nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684813(US20240228491, Example 88)
Affinity DataIC50: 16nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684771(US20240228491, Example 48)
Affinity DataIC50: 16.1nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684786(US20240228491, Example 62)
Affinity DataIC50: 16.1nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684775(US20240228491, Example 52)
Affinity DataIC50: 16.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684774(US20240228491, Example 51)
Affinity DataIC50: 16.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684744(US20240228491, Example 21)
Affinity DataIC50: 16.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684777(US20240228491, Example 54)
Affinity DataIC50: 16.2nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684801(US20240228491, Example 76)
Affinity DataIC50: 16.3nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684818(US20240228491, Example 93)
Affinity DataIC50: 16.3nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684778(US20240228491, Example 55)
Affinity DataIC50: 16.3nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684799(US20240228491, Example 74)
Affinity DataIC50: 16.4nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684746(US20240228491, Example 23)
Affinity DataIC50: 16.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684797(US20240228491, Example 72)
Affinity DataIC50: 16.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684814(US20240228491, Example 89)
Affinity DataIC50: 16.5nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684794(US20240228491, Example 69)
Affinity DataIC50: 16.6nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684815(US20240228491, Example 90)
Affinity DataIC50: 16.9nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684806(US20240228491, Example 81)
Affinity DataIC50: 17nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetS-adenosylmethionine synthase isoform type-2(Human)
Scinnohub Pharmaceutical Co.

US Patent
LigandPNGBDBM684784(US20240228491, Example 60)
Affinity DataIC50: 17nMAssay Description:The specific steps were as follows: The compounds having the test starling concentration of 1 uM or 10 uM were diluted into 10 concentration points i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

Displayed 1 to 50 (of 89 total ) | Next | Last >>
Jump to: